165 related articles for article (PubMed ID: 37746186)
21. [COVID-19-associated pulmonary aspergillosis in critically ill patients: experience of a Chilean public hospital].
Araya-Rojas F; Lasso-Barreto M
Rev Chilena Infectol; 2021 Dec; 38(6):754-760. PubMed ID: 35506848
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
24. A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data.
Lass-Flörl C; Knoll M; Posch W; Joannidis M; Mayerhöfer T; Breitkopf R; Bellmann R
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611406
[TBL] [Abstract][Full Text] [Related]
25. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
[TBL] [Abstract][Full Text] [Related]
26. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
[TBL] [Abstract][Full Text] [Related]
27. Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis.
Khodavaisy S; Hedayati MT; Alialy M; Habibi MR; Badali H
Curr Med Mycol; 2015 Mar; 1(1):12-17. PubMed ID: 28680975
[TBL] [Abstract][Full Text] [Related]
28. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
[TBL] [Abstract][Full Text] [Related]
29. COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital.
Ranhel D; Ribeiro A; Batista J; Pessanha M; Cristovam E; Duarte A; Dias A; Coelho L; Monteiro F; Freire P; Veríssimo C; Sabino R; Toscano C
J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682302
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
[TBL] [Abstract][Full Text] [Related]
32. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
[TBL] [Abstract][Full Text] [Related]
33. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E
Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880
[TBL] [Abstract][Full Text] [Related]
34. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
[TBL] [Abstract][Full Text] [Related]
36. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.
Heng SC; Morrissey O; Chen SC; Thursky K; Manser RL; Nation RL; Kong DC; Slavin M
Crit Rev Microbiol; 2015 Feb; 41(1):124-34. PubMed ID: 23799871
[TBL] [Abstract][Full Text] [Related]
37. An observational cohort study of bronchoalveolar lavage fluid galactomannan and
Gao CA; Markov NS; Pickens C; Pawlowski A; Kang M; Walter JM; Singer BD; Wunderink RG
medRxiv; 2024 Feb; ():. PubMed ID: 38370841
[TBL] [Abstract][Full Text] [Related]
38. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
[TBL] [Abstract][Full Text] [Related]
39. Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis.
Nuh A; Ramadan N; Shah A; Armstrong-James D
J Fungi (Basel); 2022 Feb; 8(2):. PubMed ID: 35205942
[TBL] [Abstract][Full Text] [Related]
40. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]